The 2010 Johnson & Johnson children's product recall involved 43 over-the-counter children's medicines announced by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, on April 30, 2010. Medications in the recall included liquid versions of Tylenol, Tylenol Plus, Motrin, Zyrtec, and Benadryl. The products were recalled after it was determined that they "may not fully meet the required manufacturing specifications". [1] [2] The recall affected at least 12 countries. [1]
During a routine inspection on April 19, federal investigators found several "manufacturing deficiencies" at a McNeil manufacturing facility in Fort Washington, Pennsylvania, United States. [3] According to the Food and Drug Administration (FDA), the plant's manufacturing process was "not in control," meaning it was using flawed procedures that could potentially lead to manufacturing errors. [3] As a result, some products "may contain a higher concentration of active ingredient than is specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny [foreign] particles." [3] Foreign particles could potentially include solidified ingredients or "manufacturing residue such as tiny metal specks" [4] or mold.
It was not clear when the problems began, but FDA official Douglas Stearn said it "does go back in time". [3] The official FDA report, released May 4, said investigators found thick dust, grime, and contaminated ingredients at the manufacturing plant. [5] Burkholderia cepacia bacteria was found on some equipment which, according to Johnson & Johnson, never was actually put into use. [6]
According to the FDA, the agency alerted Johnson & Johnson of the problem via letter on Friday, April 30. [7] That evening, McNeil announced a voluntary recall of the affected products. [3] [7] According to Johnson & Johnson spokesperson Bonnie Jacob, the company had conducted an independent internal assessment and already alerted the FDA of recall plans before the letter arrived. [7] Canada, Dominican Republic, Fiji, Guam, Guatemala, Jamaica, Kuwait, Puerto Rico, Panama, Trinidad and Tobago, the United Arab Emirates, and the United States were affected by the recall. [1] It includes all non-expired packages produced in the United States – more than 100,000 bottles of medicine in total. [3] [8] "A vast portion of the [American] children's medicine market" was affected by the recall. [3] In Canada, only Children's Motrin and Children's Tylenol Cough & Runny Nose were affected by the recall. [8]
According to the FDA, consumers should stop using the recalled products even though the chance of related health problems was "remote." [3] A McNeil spokesperson stated that the recall was not made on "the basis of adverse medical events". [3] As of May 2, no injuries or deaths have been reported. [9]
All production at the deficient plant has been voluntarily halted, but McNeil declined to state when the plant first ceased operations. [3] In a statement, Johnson & Johnson said "a comprehensive quality assessment across its manufacturing operations" was underway. [1] [2] According to a spokesperson, fixes had already been identified by May 2, and would be put in place before operation resumed. [7] A dedicated website and telephone hotline were established by the company to handle customer inquiries. [4] The phone line was initially overwhelmed by a high call volume. [4]
On May 6, The House Committee on Oversight and Government Reform launched an investigation into Johnson & Johnson, saying that the recall combined with previous recalls "point to a major problem" with the company's production. [5] "Taken together, these recalls point to a major problem in the production of McNeil products," said a statement from the panel's leadership. [5] The company issued four recalls in the preceding year, and has recalled a variety of products since. [5] [10]
Infant formula, also called baby formula, simply formula, baby milk or infant milk, is designed and marketed for feeding to babies and infants under 12 months of age, usually prepared for bottle-feeding or cup-feeding from powder or liquid. The U.S. Federal Food, Drug, and Cosmetic Act (FFDCA) defines infant formula as "a food which purports to be or is represented for special dietary use solely as a food for infants by reason of its simulation of human milk or its suitability as a complete or partial substitute for human milk".
Tylenol is a brand of medication, advertised for reducing pain, reducing fever, and relieving the symptoms of allergies, cold, cough, headache, and influenza. The active ingredient of its original flagship product is paracetamol, an analgesic and antipyretic. Like the words paracetamol and acetaminophen, the brand name Tylenol is derived from a chemical name for the compound, N-acetyl-para-aminophenol (APAP). The brand name is owned by McNeil Consumer Healthcare, a subsidiary of Kenvue.
Respironics is an American medical supply company owned by Philips that specializes in products that improve respiratory functions. It is based in the Pittsburgh suburb of Murrysville in Pennsylvania, United States.
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
The Chicago Tylenol murders were a series of poisoning deaths resulting from drug tampering in the Chicago metropolitan area in 1982. The victims consumed Tylenol-branded acetaminophen capsules that had been laced with potassium cyanide. Seven people died in the original poisonings, and there were several more deaths in subsequent copycat crimes.
Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold. It is also less commonly used for tremors in parkinsonism, and nausea. It is taken by mouth, injected into a vein, injected into a muscle, or applied to the skin. Maximal effect is typically around two hours after a dose, and effects can last for up to seven hours.
Melamine is an organic compound with the formula C3H6N6. This white solid is a trimer of cyanamide, with a 1,3,5-triazine skeleton. Like cyanamide, it contains 66% nitrogen by mass, and its derivatives have fire-retardant properties due to its release of nitrogen gas when burned or charred. Melamine can be combined with formaldehyde and other agents to produce melamine resins. Such resins are characteristically durable thermosetting plastic used in high pressure decorative laminates such as Formica, melamine dinnerware including cooking utensils, plates, plastic products, laminate flooring, and dry erase boards. Melamine foam is used as insulation, soundproofing material and in polymeric cleaning products, such as Magic Eraser.
Benadryl is a brand of various antihistamine medications used to stop allergies, whose content varies in different countries, but which includes some combination of diphenhydramine, acrivastine, and/or cetirizine.
A product recall is a request from a manufacturer to return a product after the discovery of safety issues or product defects that might endanger the consumer or put the maker or seller at risk of legal action. Product recalls are one of a number of corrective actions that can be taken for products that are deemed to be unsafe.
Excedrin is an over-the-counter headache pain reliever, typically in the form of tablets or caplets. It contains paracetamol, aspirin and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other products from BMS's over-the-counter business. As of March 2015, GSK holds majority ownership of Excedrin through a joint venture transaction with Novartis. On July 18, 2022, GSK spun off its consumer healthcare business to Haleon.
Sibutramine, formerly sold under the brand name Meridia among others, is an appetite suppressant which has been discontinued in many countries. It works as a serotonin–norepinephrine reuptake inhibitor similar to a tricyclic antidepressant. Until 2010, it was widely marketed and prescribed as an adjunct in the treatment of obesity along with diet and exercise. It has been associated with increased cardiovascular diseases and strokes and has been withdrawn from the market in 2010 in several countries and regions including Australia, Canada, China, the European Union, Hong Kong, India, Mexico, New Zealand, the Philippines, Thailand, the United Kingdom, and the United States. However, the drug remains available in some countries.
Rolaids is an American brand of calcium and magnesium-based antacid produced by Procter & Gamble. It was invented by American chemist Irvine W. Grote in the late 1920s, and originated with manufacturing in Chattanooga, Tennessee, under one of Chattem's forerunner companies, which manufactured the brand for Warner-Lambert; Warner-Lambert merged with Pfizer in 2000.
Sominex is the trademarked name for several over the counter sleep aids.
Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine and works by blocking histamine H1 receptors.
In the field of pharmacy, compounding is preparation of custom medications to fit unique needs of patients that cannot be met with mass-produced products. This may be done, for example, to provide medication in a form easier for a given patient to ingest, or to avoid a non-active ingredient a patient is allergic to, or to provide an exact dose that isn't otherwise available. This kind of patient-specific compounding, according to a prescriber's specifications, is referred to as "traditional" compounding. The nature of patient need for such customization can range from absolute necessity to individual optimality to even preference.
McNeil Consumer Healthcare is an American medicals products company belonging to Kenvue consumer health group. It primarily sells fast-moving consumer goods such as over-the-counter drugs.
In China, the adulteration and contamination of several food and feed ingredients with inexpensive melamine and other compounds, such as cyanuric acid, ammeline and ammelide, are common practice. These adulterants can be used to inflate the apparent protein content of products, so that inexpensive ingredients can pass for more expensive, concentrated proteins. Melamine by itself has not been thought to be very toxic to animals or humans except possibly in very high concentrations, but the combination of melamine and cyanuric acid has been implicated in kidney failure. Reports that cyanuric acid may be an independently and potentially widely used adulterant in China have heightened concerns for both animal and human health.
Dick Van Patten's Natural Balance Pet Foods is an American pet food manufacturer with its headquarters located in Burbank, Los Angeles, California. Established in 1989 by actor Dick Van Patten, the company markets itself as "Food For a Lifetime" and promotes itself as having "the finest food you can buy for your pet." A subsidiary of Big Heart Pet Brands, it was previously owned by the J.M. Smucker Company until February 2021, when it was sold to Nexus Capital Management LP.
Robert Lincoln McNeil Jr. was an American chemist and pharmaceutical industry executive. He was responsible for, among other things, the commercial development, naming, and introduction of the pain reliever Tylenol.